| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Jan 03, 2023 | Option Exercise | $12.84 | 30,000 | 385,350 | 40,055 | Jan 05, 2023, 06:21 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Jan 03, 2023 | Sale | $118.86 | 30,000 | 3,565,728 | 25,055 | Jan 05, 2023, 06:21 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Jan 24, 2022 | Sale | $74.43 | 15,000 | 1,116,378 | 25,055 | Jan 26, 2022, 05:52 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Jan 24, 2022 | Option Exercise | $6.66 | 15,000 | 99,900 | 40,055 | Jan 26, 2022, 05:52 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 28, 2020 | Sale | $99.39 | 17,687 | 1,757,966 | 29,861 | Apr 30, 2020, 04:27 PM | |
| BIIB | BIOGEN INC. | SHERWIN STEPHEN A | Director | Mar 11, 2020 | Option Exercise | $58.46 | 12,278 | 717,772 | 16,517 | Mar 12, 2020, 06:56 PM | |
| BIIB | BIOGEN INC. | SHERWIN STEPHEN A | Director | Mar 11, 2020 | Sale | $295.22 | 2,434 | 718,574 | 15,438 | Mar 12, 2020, 06:56 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Jun 11, 2018 | Sale | $98.44 | 10,000 | 984,420 | 47,548 | Jun 13, 2018, 12:34 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 26, 2018 | Option Exercise | $79.44 | 1,331 | 105,735 | 57,548 | Apr 30, 2018, 04:03 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 26, 2018 | Option Exercise | $7.05 | 15,000 | 105,750 | 58,879 | Apr 30, 2018, 04:03 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Feb 07, 2017 | Option Exercise | $43.60 | 1,169 | 50,968 | 43,879 | Feb 08, 2017, 07:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Feb 07, 2017 | Option Exercise | $3.40 | 15,000 | 51,000 | 45,048 | Feb 08, 2017, 07:38 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 14, 2016 | Option Exercise | $3.07 | 15,000 | 46,050 | 31,030 | Apr 18, 2016, 06:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 14, 2016 | Option Exercise | $46.86 | 982 | 46,017 | 30,048 | Apr 18, 2016, 06:02 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 07, 2015 | Option Exercise | $40.20 | 1,776 | 71,395 | 16,030 | Jan 12, 2016, 06:06 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 07, 2015 | Option Exercise | $4.76 | 15,000 | 71,400 | 17,806 | Jan 12, 2016, 06:06 PM | |
| VICL | VICAL INC | SHERWIN STEPHEN A | Director | May 21, 2015 | Option Exercise | $0.01000 | 7,500 | 75 | 22,003 | May 26, 2015, 01:25 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Mar 10, 2015 | Option Exercise | $59.82 | 6,000 | 358,920 | 10,150 | Mar 11, 2015, 04:17 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Mar 10, 2015 | Sale | $409.67 | 6,000 | 2,458,020 | 4,150 | Mar 11, 2015, 04:17 PM | |
| VSTM | Verastem, Inc. | SHERWIN STEPHEN A | Director | Dec 26, 2014 | Buy | $8.56 | 2,500 | 21,395 | 2,500 | Dec 29, 2014, 09:45 AM | |
| VICL | VICAL INC | SHERWIN STEPHEN A | Director | May 22, 2014 | Option Exercise | $0.01000 | 7,500 | 75 | 14,503 | May 23, 2014, 05:36 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 16, 2014 | Option Exercise | $12.37 | 12,000 | 148,440 | 13,531 | Apr 18, 2014, 02:34 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Apr 16, 2014 | Option Exercise | $13.84 | 10,725 | 148,434 | 2,806 | Apr 18, 2014, 02:34 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Jan 02, 2014 | Option Exercise | $59.82 | 5,500 | 329,010 | 9,460 | Jan 06, 2014, 11:19 AM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Jan 02, 2014 | Sale | $279.28 | 5,500 | 1,536,059 | 7,660 | Jan 06, 2014, 11:19 AM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Jun 03, 2013 | Option Exercise | $59.82 | 12,825 | 767,191 | 15,480 | Jun 04, 2013, 03:26 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Jun 03, 2013 | Sale | $233.26 | 12,825 | 2,991,605 | 12,047 | Jun 04, 2013, 03:26 PM | |
| VICL | VICAL INC | SHERWIN STEPHEN A | Director | May 23, 2013 | Buy | $0.01000 | 7,003 | 70 | 7,003 | May 28, 2013, 06:42 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Mar 28, 2013 | Option Exercise | $12.15 | 10,469 | 127,198 | 1,531 | Apr 01, 2013, 05:22 PM | |
| NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | Mar 28, 2013 | Option Exercise | $10.60 | 12,000 | 127,200 | 12,000 | Apr 01, 2013, 05:22 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Mar 22, 2013 | Sale | $176.88 | 1,500 | 265,320 | 2,655 | Mar 25, 2013, 02:18 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Sep 04, 2012 | Sale | $145.90 | 2,000 | 291,800 | 4,155 | Sep 05, 2012, 03:20 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Jun 04, 2012 | Sale | $126.45 | 2,500 | 316,125 | 4,135 | Jun 05, 2012, 03:43 PM | |
| BIIB | BIOGEN IDEC INC. | SHERWIN STEPHEN A | Director | Dec 19, 2011 | Sale | $110.88 | 2,500 | 277,200 | 6,635 | Dec 20, 2011, 03:10 PM |
Menu